One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines,...
Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees increased...
National Vision Holdings, Inc. EYE is winning market shares across four sub segments of the Owned and Host. The company is also advancing its transformation efforts with continued expansion of exam capacity,...
Neogen's NEOG vast international trade is being impacted by global macroeconomic issues. Also, a tough competitive landscape weighs on the stock. NEOG stock carries a Zacks Rank #4 (Sell) currently.Factors...
Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks Rank...
The Ensign Group, Inc. ENSG is benefiting from strategic acquisitions, an expanding footprint, rising service revenues and a strong financial position. An optimistic 2024 business outlook also reinforces...
Through 2024, advancements in AI and predictive analytics rapidly revolutionized the Medical Instruments industry, driving innovation in diagnostics, patient monitoring and personalized treatment. AI-powered...
John Leite, the Chief Commercial Officer-CLIA of $VCYT ($VCYT), sold 1,050 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...